Literature DB >> 23204018

Personalised medicine in exacerbations of COPD: the beginnings.

Sanjay Sethi.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23204018     DOI： 10.1183/09031936.00136412

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

1.  New and emerging technologies for the diagnosis and monitoring of chronic obstructive pulmonary disease: A horizon scanning review.

Authors:  Louise C Dixon; Derek J Ward; Joanna Smith; Steve Holmes; Ravi Mahadeva
Journal:  Chron Respir Dis       Date:  2016-06-23       Impact factor: 2.444

2.  Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation.

Authors:  Jill A Ohar; Glenn D Crater; Amanda Emmett; Thomas J Ferro; Andrea N Morris; Ibrahim Raphiou; Peruvemba S Sriram; Mark T Dransfield
Journal:  Respir Res       Date:  2014-09-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.